Processes for recovering and purifying polyhydroxyalkanoates from cell cultures
A process for recovering and purifying polyhydroxyalkanoates from a cell culture may include: (a) acidifying the culture to obtain a pH value less than or equal to 6, and submitting the culture to a cell fractionation treatment using high-pressure homogenization at a temperature greater than or equal to 10° C. and less than or equal to 80° C. to obtain a suspension; (b) basifying the suspension to obtain a pH value greater than or equal to 8; (c) diluting the suspension and submitting the diluted PHA suspension to tangential filtration to obtain a concentrated suspension as retentate and an aqueous phase as permeate; (d) submitting the concentrated suspension to bleaching; (e) diluting the suspension after the bleaching and submitting the diluted bleached suspension to tangential filtration to obtain a concentrated bleached suspension as retentate and an aqueous phase as permeate; and/or (f) submitting the concentrated bleached suspension to drying.
1. A process for recovering and purifying polyhydroxyalkanoates (PHA) from a cell culture, the process comprising:
(a) acidifying the cell culture by adding an aqueous solution of an inorganic or organic acid selected from: sulfuric acid, hydrochloric acid, phosphoric acid, nitric acid, acetic acid, citric acid, or mixtures thereof, so as to obtain a pH value less than or equal to 6, and submitting the cell culture to a cell fractionation treatment using high-pressure homogenization at a temperature greater than or equal to 10° C. and less than or equal to 80° C., so as to obtain a PHA suspension;
(b) basifying the PHA suspension thus obtained so as to obtain a pH value greater than or equal to 8;
(c) diluting the PHA suspension and submitting the diluted PHA suspension to first tangential filtration so as to obtain a concentrated PHA suspension as first retentate and a first aqueous phase as first permeate;
(d) submitting the concentrated PHA suspension to bleaching;
(e) diluting the PHA suspension after the bleaching and submitting the diluted bleached suspension to second tangential filtration so as to obtain a concentrated bleached PHA suspension as second retentate and a second aqueous phase as second permeate; and
(f) submitting the concentrated bleached PHA suspension to drying.
2. The process of claim 1 , wherein the cell culture is submitted to a preliminary step of concentration.
3. The process of claim 2 , wherein the preliminary step of concentration yields a cell concentration greater than or equal to 20 grams/liter (g/L) and less than or equal to 800 g/L.
4. The process of claim 1 , wherein in step (a), the cell culture is acidified so as to obtain a pH value less than or equal to 5.
5. The process of claim 1 , wherein a pressure greater than or equal to 500 bar and less than or equal to 2,000 bar is applied during the homogenization.
6. The process of claim 1 , wherein in step (b), the PHA suspension is basified so as to obtain a pH value greater than or equal to 9.
7. The process of claim 1 , wherein the PHA suspension thus basified is treated with at least one surfactant at a temperature greater than or equal to 10° C. and less than or equal to 80° C.
8. The process of claim 1 , wherein after the treatment according to step (b), the PHA suspension is diluted so as to obtain a solid concentration greater than or equal to 10 grams/liter (g/L) and less than or equal to 500 g/L.
9. The process of claim 1 , wherein in at least one of the tangential filtration steps, at least one ceramic or polymeric membrane is used, having a mean pore dimension greater than or equal to 0.05 microns (μm) and less than or equal to 10 μm.
10. The process of claim 1 , wherein in at least one of the tangential filtration steps, the PHA suspension is fed through at least one tangential flow filter with a pressure greater than or equal to 1 bar and less than or equal to 10 bar.
11. The process of claim 1 , wherein in at least one of the tangential filtration steps, flow speed greater than or equal to 2 m/sec and less than or equal to 10 meters/second is maintained through at least one tangential flow filter.
12. The process of claim 1 , wherein the bleaching step (d) is carried out by adding oxidizing agent.
13. The process of claim 1 , wherein the bleaching step (d) is carried out at a temperature greater than or equal to 10° C. and less than or equal to 60° C.
14. The process of claim 1 , wherein after the treatment according to step (d), the bleached PHA suspension is diluted so as to obtain a solid concentration greater than or equal to 10 grams/liter (g/L) and less than or equal to 100 g/L.
15. The process of claim 1 , wherein the concentrated bleached PHA suspension obtained from step (e) is further concentrated using orthogonal filtration and then directed to the drying step (f).
16. The process of claim 15 , wherein at least one flocculating agent is added to the concentrated bleached PHA suspension, and a resulting combination is then fed to the orthogonal filtration step.
17. The process of claim 1 , wherein a pressure greater than or equal to 500 bar and less than or equal to 1.500 bar is applied during the homogenization.
18. The process of claim 1 , wherein the PHA suspension thus basified is treated with at least one surfactant at a temperature greater than or equal to 20° C. and less than or equal to 50° C.
19. The process of claim 1 , wherein after the treatment according to step (b), the PHA suspension is diluted so as to obtain a solid concentration greater than or equal to 25 grams/liter (g/L) and less than or equal to 100 g/L.
20. The process of claim 1 , wherein in at least one of the tangential filtration steps, at least one ceramic or polymeric membrane is used, having a mean pore dimension greater than or equal to 0.2 microns (μm) and less than or equal to 5 μm.